Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Echelon Biosciences

Echelon Biosciences?uq=kzBhZRuG
1997 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Operator of a pharmaceutical research company. The company is engaged in the study of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections and cardiovascular disease.

Formerly Known As
Echelon Research Laboratories
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Frontier Scientific
Primary Office
  • 675 Arapeen Drive
  • Suite 302
  • Salt Lake City, UT 84108
  • United States

+1 (801) 000-0000

Echelon Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Echelon Biosciences‘s full profile, request access.

Request full access to PitchBook

Echelon Biosciences Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Echelon Biosciences‘s full profile, request access.

Request full access to PitchBook

Echelon Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
W. Tim Miller President & Chief Executive Officer
Bert Israelsen Chief Operating Officer